Ethical considerations in the management of drug severe cutaneous adverse reactions.

Buckey, Timothy M; Ferreira, Alana L; Grant-Kels, Jane M.

Afiliación

Buckey TM; Section of Allergy & Immunology, Division of Pulmonary, Allergy, and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Ferreira AL; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Grant-Kels JM; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut; Department of Dermatology, University of Florida, Gainesville, Florida. Electronic address: grant@uchc.edu.

J Am Acad Dermatol ; 2024 Jan 13.

Article en En | MEDLINE | ID: mdl-38224911

Palabras clave

Stevens-Johnson syndrome (SJS); acute generalized exanthematous pustulosis (AGEP); autonomy; drug challenge; drug reaction with eosinophilia and systemic symptoms (DRESS); ethics; informed consent; nonmaleficence; severe cutaneous adverse reaction (SCAR); shared decision-making; toxic epidermal necrolysis (TEN); trimethoprim-sulfamethoxazole (TMP-SMX)